Health News & Press Release Distribution

Health

APAC
Global

China Jo-Jo Drugstores Granted A Second Extension to Meet Nasdaq Minimum Bid Price Requirement

HANGZHOU, China, Dec. 14, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that on December 13, 2023, t...

2023-12-14 21:30 3290

Titans Gather, Future Embarks: The GenScript Biotech Global Forum coinciding with the 2024 J.P. Morgan Healthcare Conference in San Francisco to Convene 20+ KOLs, Exploring Disruptive Transformations and Infinite Opportunities in GCT

Keynote speaker Peter Marks to Deliver Address Free Early Bird Registration Closing Soon NANJING, China, Dec. 14, 2023 /PRNewswire/ -- Technological advancements continuously empower the life sciences. Gene and cell therapy (GCT), as breakthrough treatments, are turning the once-unreachable dre...

2023-12-14 20:34 2184

BD to become exclusive global license partner (excluding China) for Bactiguard coated Foley catheters

STOCKHOLM, Dec. 14, 2023 /PRNewswire/ -- Bactiguard Holding AB (publ.) today announces strengthened ties with leading global medical technology company Becton Dickinson & Company (BD), Bactiguard's longest and strongest license collaboration. An interim agreement has been signed granting BD an exc...

2023-12-14 17:53 1388

Vantage Foundation's Wishing Well Initiative Brings Joy To Rumah Hope Children's Home In Malaysia

PETALING JAYA, Malaysia, Dec. 14, 2023 /PRNewswire/ -- This holiday season, Vantage Foundation is lighting up the lives of underprivileged youth at Rumah Hope Children's Home inMalaysia with a heartwarming initiative designed to foster sensitivity and inclusivity during festive holidays. The "...

2023-12-14 17:05 1706

Vantage Foundation's Wishing Well Initiative Brings Joy To Rumah Hope Children's Home In Malaysia

Fosun Pharma's Global Multi-Center Phase III Clinical Trial Project for A New Antimalarial Drug Receives 500 Million Japanese Yen Investment from GHIT Fund to Jointly Improve the Global Accessibility of Antimalarial Drugs

SHANGHAI, Dec. 14, 2023 /PRNewswire/ -- The Japan-based Global Health Innovative Technology Fund (GHIT Fund) announced today that it will invest approximatelyUS$3.3 million (approximately 500 million yen[1]) in a global multicenter Phase III clinical trial project (the "Program") led by Fosun Ph...

2023-12-14 17:00 3508

MGI Australia unveils its CEC with DCS Lab products featuring pioneering technology in DNA, Cell, and Spatial-omics Technology

Australia first market outside China to access revolutionary new capability BRISBANE, Australia, Dec. 14, 2023 /PRNewswire/ -- MGI Australia, a subsidiary ofMGI Tech Co. Ltd. (MGI), a global leader i...

2023-12-14 13:13 1861

MGI Australia unveils its CEC with DCS Lab products featuring pioneering technology in DNA, Cell, and Spatial-omics Technology

Pretty Beauty Group Leads the Beauty Tech Trend with the Introduction of LDM Triple 19

HONG KONG, Dec. 14, 2023 /PRNewswire/ -- Pretty Beauty Group once again demonstrates its commitment to leading the market by introducing a revolutionary beauty device - LDM Triple 19. This groundbreaking technology, known as the LDM® Skin Cell Regeneration Device, has been meticulously developed...

2023-12-14 12:27 1398

Antengene Announces Inclusion of XPOVIO® (selinexor) in 2023 China's National Reimbursement Drug List

SHANGHAI and HONG KONG, Dec. 14, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cance...

2023-12-14 09:55 1641

The Inaugural Fosun Health Conference on Guangdong-Hong Kong-Macao Healthcare Development Integration Held in Hong Kong to Promote "Three Links" Development

HONG KONG, Dec. 14, 2023 /PRNewswire/ -- The Inaugural Fosun Health Conference onGuangdong-Hong Kong-Macao Healthcare Development Integration was successfully held inHong Kong by Fosun Health on December 12, 2023. With the background of integrating medical services ofGuangdong, Hong Kong and Maca...

2023-12-14 09:00 3491

Abbisko Therapeutics Announces that U.S. FDA Has Granted Fast Track Designation for Its CSF-1R Inhibitor Pimicotinib (ABSK021)

SHANGHAI, Dec. 13, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics") today announced that its CSF-1R inhibitor pimicotinib (ABSK021) has been granted the fast track designation ("FTD") by the U.S. FDA for the treatment of tenosynovial giant cell tumor ("TGCT") patients ...

2023-12-14 08:30 1339

Crown Aesthetics Announces Groundbreaking Study on Skin Microbiome-Optimized BIOJUVE™ Regimen

Study Reveals Remarkable Results in Aesthetic Treatment Recovery DALLAS, Dec. 14, 2023 /PRNewswire/ -- Crown Aesthetics, a Crown Laboratories, Inc. company ("Crown"), announced today that its groundbreaking clinical study, recently accepted for publication in the Journal of Clinical and Aesthetic...

2023-12-14 03:56 1368

GREATER DES MOINES PARTNERSHIP ANNUAL DINNER SPEAKER ANNOUNCED

GREATER DES MOINES, Iowa, Dec. 13, 2023 /PRNewswire/ -- The Greater Des Moines Partnership has announced that its 2024 Annual Dinner will take place on Thursday, Jan. 25, 2024 at the Community Choice Credit Union Convention Center. The Partnership's Annual Dinner is the Greater Des Moines (DSM) bu...

2023-12-13 22:30 1390

COP28: Angel Yeast's Environmentally Friendly Yeast Protein Empowers Sustainability Development

SHANGHAI, Dec. 13, 2023 /PRNewswire/ -- Angel Yeast , (SH600298), the world's leading yeast manufacturer, is responding to the call of action ofCOP28 which is taking place from November 30 to December 12 in Dubai with concrete actions and sustainable solutions.

2023-12-13 22:04 2319

COP28: Angel Yeast's Environmentally Friendly Yeast Protein Empowers Sustainability Development

WAT Medical Joins World's Largest Boat Show

VANCOUVER, BC, Dec. 13, 2023 /PRNewswire/ -- Discover Boating Miami International Boat Show (DBMIBS) is the world's largest boat and yacht show. The convention, which attracts over 100,000 visitors from more than 35 countries, provides an opportunity for aquatic innovations and consumer products...

2023-12-13 22:00 1271

WAT Medical Joins World's Largest Boat Show

Immunocan Provides Update on Business Operations, Highlighting Launch of New Gene-edited Mice Generating Fully Human Heavy-chain-only Antibodies and Advances in Partner Pipeline

SHANGHAI, Dec. 13, 2023 /PRNewswire/ -- Shanghai Immunocan Biotech Co., Ltd. ("Immunocan") announcesthe launch of its ImmuMab Heavy® mice. These gene-edited mice, developed by modifying the constant region genes of heavy chains in the ImmuMab® mouse, generate fully human heavy-chain-only antibodi...

2023-12-13 22:00 1522

Virtual twin to improve treatment with cancer immunotherapies

COLOGNE, Germany, Dec. 13, 2023 /PRNewswire/ -- An international team started the research project CERTAINTY inDecember 2023. Together with partners from science, industry and the healthcare sector, the project team led by the Fraunhofer Institute for Cell Therapy and Immunology IZI aims to devel...

2023-12-13 21:06 1164

Molecular Loop Biosciences Receives $1.8 Million to Expand Multi-pathogen Genomics Products for Respiratory Infections

WOBURN, Mass., Dec. 13, 2023 /PRNewswire/ -- Molecular Loop Biosciences, Inc., an innovator at the forefront of targeted sequencing technologies, is pleased to announce that it has received a$1.8 million grant from the Bill & Melinda Gates Foundation to further its groundbreaking work in the fiel...

2023-12-13 21:00 1401

Alebund Reports Update for AP306 (EOS789), a First-in-Class Pan-inhibitor of Sodium-dependent Phosphate Transporters, from a Completed Phase II Clinical Trial in Patients with Hyperphosphatemia on Hemodialysis

SHANGHAI, Dec. 13, 2023 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, announcedphase II proof-...

2023-12-13 21:00 1434

Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense® HER2 Imaging Agent

MELBOURNE, Australia and SAN DIEGO, Dec. 13, 2023 /PRNewswire/ -- Imagion Biosystems Limited (ASX: IBX) recently announced positive results following completion of the IBI10103 phase I clinical trial evaluating the safety and clinical feasibility ofMagSense® HER2 Imaging Agent (MSH2IA) as an adju...

2023-12-13 19:00 1669

Transcenta Announces the Publication of Preclinical Results of [177Lu]Lu-TST001 Radionuclide Antibody Conjugate as Potential Novel Treatment Option for Metastatic Gastric Cancer in the European Journal of Nuclear Medicine and Molecular Imaging

PRINCETON, N.J. and SUZHOU, China, Dec. 13, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces ...

2023-12-13 18:01 1860

1 ... 54 55 565758 59 60 ... 820